New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - cilazapril monohydrate 5.213mg equivalent to 5 mg cilazapril - film coated tablet - 5 mg - active: cilazapril monohydrate 5.213mg equivalent to 5 mg cilazapril excipient: hyprolose hypromellose iron oxide red macrogol 8000 maize starch microcrystalline cellulose purified water sodium stearyl fumarate - apo-cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension.

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - cilazapril monohydrate 5.22mg equivalent to 5 mg cilazapril base; hydrochlorothiazide 12.5mg - film coated tablet - 5 mg/12.5 mg - active: cilazapril monohydrate 5.22mg equivalent to 5 mg cilazapril base hydrochlorothiazide 12.5mg excipient: hyprolose hypromellose iron oxide red macrogol 8000 maize starch microcrystalline cellulose sodium stearyl fumarate titanium dioxide - apo-cilazapril/hctz is indicated for the treatment of patients with hypertension who are not adequately controlled on monotherapy.

Canada - English - Health Canada

teva canada limited - cilazapril (cilazapril monohydrate); hydrochlorothiazide - tablet - 5mg; 12.5mg - cilazapril (cilazapril monohydrate) 5mg; hydrochlorothiazide 12.5mg - angiotensin-converting enzyme inhibitors

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - cilazapril monohydrate 1.0425mg equivalent to 1 mg cilazapril - film coated tablet - 1 mg - active: cilazapril monohydrate 1.0425mg equivalent to 1 mg cilazapril excipient: hyprolose hypromellose iron oxide yellow macrogol 8000 maize starch microcrystalline cellulose purified water sodium stearyl fumarate titanium dioxide - apo-cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril as monohydrate; hydrochlorothiazide - tablets - cilazapril as monohydrate 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril as monohydrate; hydrochlorothiazide - tablets - cilazapril as monohydrate 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

Canada - English - Health Canada

apotex inc - cilazapril (cilazapril monohydrate); hydrochlorothiazide - tablet - 5mg; 12.5mg - cilazapril (cilazapril monohydrate) 5mg; hydrochlorothiazide 12.5mg - angiotensin-converting enzyme inhibitors

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - cilazapril monohydrate 2.606mg equivalent to 2.5 mg cilazapril - film coated tablet - 2.5 mg - active: cilazapril monohydrate 2.606mg equivalent to 2.5 mg cilazapril excipient: hyprolose hypromellose iron oxide red macrogol 8000 maize starch microcrystalline cellulose purified water sodium stearyl fumarate titanium dioxide - apo-cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cilazapril monohydrate 1.043mg equivalent to cilazapril 1 mg;   - tablet - 1 mg - active: cilazapril monohydrate 1.043mg equivalent to cilazapril 1 mg   excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow 85f92084 purified water - cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. cilazapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cilazapril monohydrate 2.608mg equivalent to cilazapril 2.5 mg;   - tablet - 2.5 mg - active: cilazapril monohydrate 2.608mg equivalent to cilazapril 2.5 mg   excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink 85f14364 purified water - cilazapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. cilazapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.